Breaking News
Investing Pro 0
New Year’s SALE: Up to 40% OFF InvestingPro+ CLAIM OFFER
Close

WuXi Biologics (2269)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
70.95 -0.45    -0.63%
03:08:01 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG970081173 
  • Volume: 11,477,611
  • Bid/Ask: 70.90 / 70.95
  • Day's Range: 69.85 - 72.00
WuXi Biologics 70.95 -0.45 -0.63%

2269 Ratios

 
Assess the performance of WuXi Biologics (2269). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on WuXi Biologics's latest financial reports. Compare the performance metrics of WuXi Biologics (2269) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 64.01 24.44
Price to Sales TTM 19.96 47.46
Price to Cash Flow MRQ 112.2 32.11
Price to Free Cash Flow TTM -254.14 -13.55
Price to Book MRQ 7.58 3.84
Price to Tangible Book MRQ 8.07 4.3
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 45.42% 49.78
Gross Margin 5YA 43.02% 53.25
Operating margin TTM 30.66% -625.68
Operating margin 5YA 25.77% -12,937.69
Pretax margin TTM 37.17% -626.52
Pretax margin 5YA 30.76% -23,070.91
Net Profit margin TTM 31.18% -629.15
Net Profit margin 5YA 26.95% -23,082.72
   
Revenue/Share TTM 3.07 16.64
Basic EPS ANN 0.81 0.68
Diluted EPS ANN 0.77 0.66
Book Value/Share MRQ 8.08 10.07
Tangible Book Value/Share MRQ 7.75 8.49
Cash/Share MRQ 1.91 4.49
Cash Flow/Share TTM 0.96 0.81
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 12.06% 7.23
Return on Equity 5YA 9.84% 3.57
Return on Assets TTM 9.33% 3.93
Return on Assets 5YA 7.71% 2.78
Return on Investment TTM 8.84% 3.88
Return on Investment 5YA 7.38% 5.73
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 36.74% 6.09
EPS(TTM) vs TTM 1 Yr. Ago TTM 42.65% 5.58
5 Year EPS Growth 5YA 75.48% 23.87
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 63.53% 25.74
Sales (TTM) vs TTM 1 Yr. Ago TTM 62.1% 28.28
5 Year Sales Growth 5YA 59.75% 47.05
5 Year Capital Spending Growth 5YA 72.27% 31.87
   
Quick Ratio MRQ 1.71 2.35
Current Ratio MRQ 2.3 2.78
LT Debt to Equity MRQ 1.54% 11.02
Total Debt to Equity MRQ 12.76% 33.99
Efficiency    
Asset Turnover TTM 0.29 0.48
Inventory Turnover TTM 3.71 3.78
Revenue/Employee TTM 1.24M 1.59M
Net Income/Employee TTM 400.93K 120.06K
Receivable Turnover TTM 2.59 4.34
   
Dividend Yield ANN - 1.5
Dividend Yield 5 Year Avg. 5YA - 1.15
Dividend Growth Rate ANN 0% 6.76
Payout Ratio TTM - 21.17
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2269 Comments

Write your thoughts about WuXi Biologics
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Jame Megueni
Jame Megueni Jun 09, 2022 2:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nomura Axes WUXI BIO TP to $95.75, Rating Buy
Surachet Lertsapsuree
Surachet Lertsapsuree Dec 15, 2021 2:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What’s happen?
Jame Megueni
Jame Megueni Dec 06, 2021 10:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
M Stanley Foresees WUXI BIO Shr Rise in 30 Days, Rated Overweight with $175 TP
Jame Megueni
Jame Megueni Jun 21, 2021 10:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa Adds WUXI BIO TP to $167; Rated*** ***Buy
Jame Megueni
Jame Megueni Jun 20, 2021 10:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
C Suisse Hikes WUXI BIO TP to $158, Rated ***Outperform***
Christopher Koay
Christopher Koay Apr 23, 2021 12:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Goldman Sachs Increases TP to $131.4 Rated BUY ! 👍🏻
Jame Megueni
Jame Megueni Apr 13, 2021 3:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JPM Hikes WUXI BIO TP to $130; Rated ***Overweight***
Jame Megueni
Jame Megueni Mar 28, 2021 11:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Nomura Chops WUXI BIO TP to $116.8, Rated ***Buy***
Christopher Koay
Christopher Koay Mar 15, 2021 4:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Definitely will back to 120 by end of this year. Company future is very good. Next factory to be setup to increase capacity expansion is ongoing till 2023. Stay tune for the extraordinary earning in the coning years. Surely a high growth positive cashflow company in China 👍🏻
Jame Megueni
Jame Megueni Mar 09, 2021 10:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa: WUXI BIO ( Share Correction Overdone Entails Bottom-fish Odds, Restated ***Buy***
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email